ANTEROGEN (065660) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, ANTEROGEN (065660) reported revenue of 7.5 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
20257.5 billion KRW-2.4 billion KRW-1.4 billion KRW[source]
20246.9 billion KRW-3.7 billion KRW-2.3 billion KRW[source]
20236.5 billion KRW-5.1 billion KRW-2.8 billion KRW[source]
20226.6 billion KRW-4.6 billion KRW-6.8 billion KRW[source]
20218.1 billion KRW-2.6 billion KRW-554 million KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
202588.3 billion KRW813 million KRW87.4 billion KRW[source]
2024116.1 billion KRW5.9 billion KRW110.2 billion KRW[source]
2023149.4 billion KRW20.0 billion KRW129.4 billion KRW[source]
2022124.1 billion KRW17.3 billion KRW106.8 billion KRW[source]
2021136.7 billion KRW19.8 billion KRW116.9 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice